Olympus Aktie
| 10,35EUR | -0,21EUR | -1,94% |
WKN: 856840 / ISIN: JP3201200007
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 31 653 | 31 557 | 32 844 | 28 838 | 29 297 |
| Umsatz pro Mitarbeiter in Mio. EUR | 23,08 | 27,53 | 26,85 | 32,46 | 34,04 |
Bilanz (in Mio. JPY) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 580 162 | 694 605 | 726 357 | 800 340 | 679 443 |
| Summe Anlagevermögen | 600 855 | 663 394 | 781 951 | 733 876 | 753 383 |
| Summe Aktiva | 1 181 017 | 1 357 999 | 1 508 308 | 1 534 216 | 1 432 826 |
Bilanz (in Mio. JPY) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 785 537 | 846 637 | 867 074 | 777 030 | 681 093 |
| Summe Eigenkapital | 395 480 | 511 362 | 641 234 | 757 186 | 751 733 |
| Summe Passiva | 1 181 017 | 1 357 999 | 1 508 308 | 1 534 216 | 1 432 826 |
Adresse
| 2951 Ishikawa-cho, 192-8507 Hachioji | |
| Telefon | +81 (42) 642-2111 |
| Internet | http://www.olympus.co.jp |
Management
|
Boris Shkolnik
Chief Quality Officer & Executive Officer |
|
David Robert Hale
Independent Outside Director |
|
Frank Drewalowski
Executive Officer & Head-Gastrointestinal Solution |
|
Gabriela Castillo Kaynor
Chief Strategy Officer & Executive Officer |
|
Gary John Pruden
Independent Outside Director |
|
Hiroshi Ishino
Independent Outside Director |
|
Jimmy C. Beasley
Independent Outside Director |
|
John de Csepel
Chief Medical Officer & Executive Officer |
|
Kohei Kan
Independent Outside Director |
|
Luann Marie Pendy
Independent Outside Director |
|
Masato Iwasaki
Independent Outside Director |
|
Neil Boyden Tanner
Executive Officer & Global General Counsel |
|
Robert White
President, CEO & Representative Director |
|
Sachiko Ichikawa
Independent Outside Director |
|
Seiji Kuramoto
Chief Surgical Intervention Business Officer |
|
Shigeto Ohtsuki
Chief Human Resources Officer & Executive Officer |
|
Stephen Mark Kneebone
Chief Information Officer & Executive Officer |
|
Syed Naveed
Chief Technology Officer & Executive Officer |
|
Takaaki Sakurai
Vice President-Investor Relations |
|
Takayuki Aoyagi
Vice President-Accounting |
|
Tatsuya Izumi
Chief Financial Officer & Executive Officer |
|
Tetsuaki Mori
Head-Research & Development Strategy |
|
Tetsuo Kobayashi
Chief Manufacturing & Supply Officer |
|
Tomohisa Sakurai
Executive Officer & Head-Government Affairs |
|
Toshihiko Okubo
Director |
|
Tsuyoshi Ogura
Deputy Chief Quality Regulatory Officer |
|
Yasuo Takeuchi
Chairman |